Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business Update

4 Jan 2011 07:00

RNS Number : 8214Y
ViaLogy PLC
04 January 2011
 



 

 

VIALOGY PLC.

January 4th 2011

ViaLogy reports key advances in QuantumRD market acceptance

Pasadena, January 4, 2011. ViaLogy PLC (LSE:VIY) makes the following announcements as part of a continuing effort to keep shareholders as fully informed of its progress as is permitted by publicity rules imposed by the company's clients or business partners.

ViaLogy has successfully completed its technology demonstration project on an offshore prospect for a global non-US major exploration and production company. Results have been acknowledged by the client as beyond the scope of conventional seismic processing and analysis technology, and as a potentially unique tool in reducing exploration and production risk. The client's evaluation was carried out using rigorous global services industry standards. The work marks the first application of ViaLogy's technology for an undersea prospect, and reinforces QuantumRD's value proposition for both complex offshore and onshore prospects. A second project is now underway for the same firm, this one focused on a key onshore prospect. In both cases the exploration problems were presented to ViaLogy after conventional seismic analysis techniques had been applied extensively.

In another important development, ViaLogy reports advanced discussions with a leading non-US national oil company, following its preliminary evaluation of QuantumRD, to apply the technology to an offshore prospect for full operational analysis and de-risking of expensive wells. This firm is looking to disruptive technologies for reducing risks in new, deeper fields and non-conventional formations.

ViaLogy will figure prominently this month at Geo India 2011, India's leading annual hydrocarbon exploration and production industry gathering in New Delhi. Due to interest sparked by the company's technology and its successes in the field, ViaLogy CTO Dr. Sandeep Gulati will present an invited keynote address. In addition ViaLogy geophysicists will conduct a two-day workshop on QuantumRD technology as a fundamental advance in seismic interferometry, a focus area of India's geophysical community. Presenting the technology to scientists and industry professionals comes at the request of a number of large Asian firms, and gives ViaLogy a select outreach opportunity.

Finally, strategic partnership discussions have begun with a leading O&G services company, following exploration of links with a number of such firms. If successful such a partnership could offer a near term path to access extensive global markets.

CEO Robert Dean said, "These and related activities have been our focus for some months, and they are key milestones in our strategy to accelerate and win the acceptance of QuantumRD in global markets. I am pleased with our progress, and we are doing our best to keep shareholders informed within the limitations imposed on us. Interest in the technology has been intense with the large firms we have chosen to work with. In all cases, in order to prove the unique value of QuantumRD, we have been presented with their hardest problems, which in itself should be an accelerated proving ground for the technology in some of the world's toughest exploration environments."

Mr. Dean points out that the gestation period from enquiry to technology acceptance takes considerably longer when dealing with supermajors and global oil exploration companies. "These complex businesses have techniques and processes already in place on which they base very large capital expenditure decisions," he said. "What we bring them in QuantumRD is a powerful risk reduction tool that complements and can be integrated with existing practices. Gaining user acceptance as a standard part of their operations is what takes time, and why they typically insist on demonstration projects and extended technical discussions."

Ends

For further information contact: 

ViaLogy

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy / Catherine Leftley, Corporate Finance +44 (0) 20-7107-8000

Katie Ratner / Jeremy Stephenson, Corporate Broking +44 (0) 20-7107-8000

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery. ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magneto telluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBRGDBBUGBGBX
Date   Source Headline
5th Nov 20207:00 amRNSDirectorate Change
3rd Nov 20207:00 amRNSPartnership with Take2 Health Limited
26th Oct 20207:00 amRNSHalf-year Trading update
23rd Oct 20207:00 amRNSCQC accreditation
21st Oct 20207:00 amRNSYourgene Genomic Services collaboration with Cytox
12th Oct 20207:00 amRNSElucigene DPYD tests to be used routinely in Wales
8th Oct 20207:00 amRNSStrategic reproductive health partnership in Japan
7th Oct 20207:00 amRNSIONA®Nx awarded contract with St George’s Hospital
5th Oct 20207:00 amRNSShare Incentive Plan
1st Oct 20204:59 pmRNSCorrection: Holding(s) in Company
1st Oct 20203:29 pmRNSHolding(s) in Company
28th Sep 20207:00 amRNSLaunch of Yourgene Genomic Services
25th Sep 20205:28 pmRNSIssue of Share Options
24th Sep 202010:00 amRNSDPD reimbursement in Germany
24th Sep 20207:00 amRNSDirector/PDMR Shareholding
23rd Sep 20205:20 pmRNSExercise of Options
23rd Sep 202012:25 pmRNSDirector/PDMR Shareholding
22nd Sep 20205:14 pmRNSResult of AGM
22nd Sep 20207:00 amRNSAGM Statement
21st Sep 20207:00 amRNSUS distribution agreement for DPYD &other products
9th Sep 20207:00 amRNSAGM update and investor presentation
3rd Sep 20207:00 amRNSIONA® Nx Launch
28th Aug 20207:00 amRNSNotice of AGM & Annual Report 2020
13th Aug 20207:00 amRNSTGA approves IONA® Nx for sale in Australia
11th Aug 20207:00 amRNSAdmission of Company Considerations Shares and TVR
7th Aug 20203:42 pmRNSHolding(s) in Company
7th Aug 20203:25 pmRNSHolding(s) in Company
7th Aug 20209:48 amRNSHolding(s) in Company
5th Aug 20201:15 pmRNSResult of Placing
5th Aug 20207:00 amRNS£16.15m Placing & Close of Accelerated Bookbuild
4th Aug 20205:13 pmRNSProposed Acquisition and Placing
3rd Aug 20207:00 amRNSCE-IVD Mark for Clarigene™ SARS-CoV-2 test
29th Jul 202012:05 pmRNSAppointment of Joint Broker
28th Jul 20207:00 amRNSFinal Results
13th Jul 20201:13 pmRNSNotice of Results
30th Jun 20207:00 amRNSCOVID-19 assay launched
19th Jun 20204:44 pmRNSIssue of Share Options
16th Jun 20207:00 amRNSCollaboration in COVID-19 testing
15th Jun 20207:00 amRNSCE-IVD mark received for Illumina-based IONA® test
26th May 202012:00 pmRNSHolding(s) in Company
26th May 20207:00 amRNSCOVID-19 testing service launch; business update
20th May 20207:00 amRNSExercise of Warrants and Options
20th Apr 20207:00 amRNSYear-end Trading update: Revenues increase 86%
16th Apr 20204:41 pmRNSSecond Price Monitoring Extn
16th Apr 20204:35 pmRNSPrice Monitoring Extension
14th Apr 20204:41 pmRNSSecond Price Monitoring Extn
14th Apr 20204:36 pmRNSPrice Monitoring Extension
14th Apr 20202:06 pmRNSSecond Price Monitoring Extn
14th Apr 20202:01 pmRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSPresentation on ‘Adapting during crisis’

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.